Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
Clinical trial NCT04796454 · WITHDRAWN
Trial details
- NCT number
- NCT04796454
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2026-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.